These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1117 related items for PubMed ID: 17854859

  • 1. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M.
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [Abstract] [Full Text] [Related]

  • 2. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T, Aishima S, Taketomi A, Nishihara Y, Fujita N, Sanefuji K, Sugimachi K, Yamashita Y, Maehara Y, Tsuneyoshi M.
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [Abstract] [Full Text] [Related]

  • 3. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.
    Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
    [Abstract] [Full Text] [Related]

  • 4. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [Abstract] [Full Text] [Related]

  • 5. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, Imai K, Yonezawa S.
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T, Isse K, Shibata F, Aburatani I, Tsuneyama K, Sabit H, Harada K, Miyazaki K, Nakanuma Y.
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [Abstract] [Full Text] [Related]

  • 7. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC, Hsu C, Kao HL, Jeng YM.
    Cancer Lett; 2006 Apr 08; 235(1):34-9. PubMed ID: 16125303
    [Abstract] [Full Text] [Related]

  • 8. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
    Aishima S, Taguchi K, Terashi T, Matsuura S, Shimada M, Tsuneyoshi M.
    Mod Pathol; 2003 Oct 08; 16(10):1019-27. PubMed ID: 14559985
    [Abstract] [Full Text] [Related]

  • 9. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M.
    Mod Pathol; 2002 Nov 08; 15(11):1181-90. PubMed ID: 12429797
    [Abstract] [Full Text] [Related]

  • 10. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.
    Am J Surg Pathol; 2007 Jul 08; 31(7):1059-67. PubMed ID: 17592273
    [Abstract] [Full Text] [Related]

  • 11. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y, Aishima S, Hayashi A, Iguchi T, Fujita N, Taketomi A, Honda H, Tsuneyoshi M.
    Histopathology; 2009 Oct 08; 55(4):423-31. PubMed ID: 19817893
    [Abstract] [Full Text] [Related]

  • 12. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M, Yonezawa S, Ho JJ, Tanaka S, Irimura T, Kim YS, Sato E.
    Hepatology; 1999 Dec 08; 30(6):1347-55. PubMed ID: 10573510
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT, Chiang JM, Yeh TS, Tseng JH, Chen TC, Jan YY, Chen MF.
    Dig Liver Dis; 2008 Sep 08; 40(9):749-54. PubMed ID: 18329969
    [Abstract] [Full Text] [Related]

  • 14. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
    Nakanishi Y, Zen Y, Kondo S, Itoh T, Itatsu K, Nakanuma Y.
    Hum Pathol; 2008 Aug 08; 39(8):1153-61. PubMed ID: 18495210
    [Abstract] [Full Text] [Related]

  • 15. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
    Li Q, Wang JM, Liu C, Xiao BL, Lu JX, Zou SQ.
    Hepatobiliary Pancreat Dis Int; 2008 Feb 08; 7(1):70-5. PubMed ID: 18234642
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.
    Ann Surg Oncol; 2009 Feb 08; 16(2):395-403. PubMed ID: 19034576
    [Abstract] [Full Text] [Related]

  • 17. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.
    Obama K, Ura K, Li M, Katagiri T, Tsunoda T, Nomura A, Satoh S, Nakamura Y, Furukawa Y.
    Hepatology; 2005 Jun 08; 41(6):1339-48. PubMed ID: 15880566
    [Abstract] [Full Text] [Related]

  • 18. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
    Wang X, Zhang J, Chen J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb 08; 22(1):57-60. PubMed ID: 12903495
    [Abstract] [Full Text] [Related]

  • 19. Expression of MAGE-A3 in intrahepatic cholangiocarcinoma and its precursor lesions.
    Tsuneyama K, Sasaki M, Shimonishi T, Nakanuma Y.
    Pathol Int; 2004 Mar 08; 54(3):181-6. PubMed ID: 14989741
    [Abstract] [Full Text] [Related]

  • 20. Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions.
    Harada K, Zen Y, Kanemori Y, Chen TC, Chen MF, Yeh TS, Jan YY, Masuda S, Nimura Y, Takasawa S, Okamoto H, Nakanuma Y.
    Hepatology; 2001 May 08; 33(5):1036-42. PubMed ID: 11343228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.